Tag: biologics cdmo market trends

Biologics CDMO Market
Healthcare

Biologics CDMO Global Market to Observe Highest Growth of $36.54 Billion with an Excellent CAGR of 14.4% by 2028 | AbbVie Inc., Novartis AG, ICON PLC, Grifols SA, Lonza Group Ltd.

- by Good PR News

Overview and Scope A biologics contract development and manufacturing organization (CDMO) is a service provider that supports pharmaceutical companies in the development and production of biologic drugs, which include vaccines, …

Biologics CDMO Global Market to Observe Highest Growth of $36.54 Billion with an Excellent CAGR of 14.4% by 2028 | AbbVie Inc., Novartis AG, ICON PLC, Grifols SA, Lonza Group Ltd. Read More